Analgesics in Norway

Date: September 22, 2016
Pages: 26
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A02F221CB56EN
Leaflet:

Download PDF Leaflet

Sales of analgesics in Norway are, relative to the rest of Western Europe, quite deregulated and liberal, and this has potentially led to increasing misuse amongst Norwegian teenagers. In 2016, grocery retailers accounted for 26% of sales, with chemist/pharmacies still representing the lion’s share (71%) of sales. Analgesics sold through grocery retailers in Norway are sold behind the counter and have an age limit of 18 years. Chemists/pharmacies have no age limit, but in return are supposed to...

Euromonitor International's Analgesics in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Analgesics by Category: Value 2011-2016
  Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
  Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
  Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
  Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Weifa As in Consumer Health (norway)
Strategic Direction
Key Facts
  Summary 1 Weifa AS: Key Facts
  Summary 2 Weifa AS: Operational Indicators
Competitive Positioning
  Summary 3 Weifa AS: Competitive Position 2016
Executive Summary
Consumer Health Still Growing
Consumer Health Is Getting More Media Attention
Competitive Landscape Remains the Same
Internet Retailing Is Here To Stay and Grow
Consumer Health Growth Expected To Slow Down
Key Trends and Developments
Media and Its Role in Consumer Health
Internet Continues To Influence Consumer Behaviour
Lifestyle and Demographics
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
  Table 9 Life Expectancy at Birth 2011-2016
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2011-2016
  Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
  Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
  Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
  Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
  Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 4 OTC: Switches 2014-2016
Sources
  Summary 5 Research Sources












Skip to top


NRT Smoking Cessation Aids in Norway US$ 990.00 Sep, 2016 · 22 pages
Wound Care in Norway US$ 990.00 Sep, 2016 · 25 pages
Life Insurance in Norway US$ 350.00 Jan, 2014 · 35 pages

Ask Your Question

Analgesics in Norway
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: